ZYME - Zymeworks Inc.
NEXT EARNINGS:
Mar 4, 2026
(in 7 days)
EPS Est: $-0.35
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$34.67
DETAILS
HIGH:
$40.00
LOW:
$26.00
MEDIAN:
$35.00
CONSENSUS:
$34.67
UPSIDE:
46.72%
Market Cap:
1.77B
Volume:
426,749
Avg Volume:
801,316
52 Week Range:
9.03-28.49
Sector:
Healthcare
Industry:
Biotechnology
Beta:
1.24
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
CA
Employees:
299
IPO Date:
2017-04-28
EPS (TTM):
-1.62
P/E Ratio:
-9.05
Revenue (TTM):
76.30M
Total Assets:
463.09M
Total Debt:
18.51M
Cash & Equiv:
66.10M
Rev Growth (5Y):
20.9%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-32.0%
Debt/Equity:
0.05
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-06 | $-0.26 | $-0.30 | +13.3% | $27.6M | $19.5M | +41.7% |
| 2025-08-07 | $0.03 | $-0.52 | +105.8% | $48.7M | $25.7M | +89.3% |
| 2025-05-08 | $-0.30 | $-0.45 | +33.3% | $27.1M | $18.0M | +50.4% |
| 2025-03-05 | $-0.31 | $0.01 | -3200.0% | $31.0M | $15.2M | +104.2% |
| 2024-10-31 | $-0.39 | $-0.40 | +2.5% | $16.0M | $47.1M | -66.0% |
| 2024-08-01 | $-0.49 | $-0.42 | -17.4% | $19.2M | $11.9M | +61.2% |
| 2024-05-02 | $-0.42 | $-0.31 | -35.5% | $10.0M | $17.5M | -42.7% |
| 2024-03-06 | $-0.20 | $-0.39 | +48.7% | $16.9M | $17.7M | -4.2% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 76.30M | 76.01M | 412.48M | 26.68M | 38.95M | 29.54M | 53.02M | 51.76M | 11.01M | 9.66M | 1.67M |
| Net Income | (122.69M) | (118.67M) | 124.34M | (211.84M) | (180.55M) | (145.44M) | (36.56M) | (10.41M) | (33.81M) | (19.17M) | (12.94M) |
| EPS | -1.62 | -1.72 | 1.91 | -4.06 | -3.58 | -3.83 | -1.26 | -0.49 | -1.72 | -0.97 | -0.65 |
| Total Assets | 463.09M | 580.88M | 648.73M | 389.13M | 538.38M | 368.20M | 244.36M | 131.96M | 94.00M | 23.15M | 50.68M |
| Total Debt | 18.51M | 26.72M | 28.11M | 32.33M | 8.64M | 6.93M | 57,000 | 62,000 | 4.42M | 6,000 | 0 |
| Cash & Equivalents | 66.10M | 157.56M | 400.91M | 201.87M | 242.04M | 128.45M | 42.20M | 35.95M | 16.44M | 11.52M | 46.84M |
| Operating Cash Flow | (110.04M) | (118.30M) | 144.11M | (192.45M) | (151.40M) | (81.85M) | 24.18M | 219,000 | (35.25M) | (22.17M) | (7.02M) |
| Free Cash Flow | (113.11M) | (122.38M) | 130.98M | (205.74M) | (157.67M) | (95.73M) | 20.76M | (2.90M) | (40.71M) | (23.02M) | (7.30M) |
| FCF per Share | -1.49 | -1.78 | 2.01 | -3.95 | -3.13 | -2.52 | 0.72 | -0.14 | -2.07 | -1.16 | -0.37 |
| Book Value | 338.77M | 464.81M | 492.96M | 249.09M | 409.92M | 245.68M | (145.27M) | 116.43M | 9.00M | 18.24M | 39.76M |
| Cash & ST Investments | 225.78M | 374.33M | 492.23M | 252.61M | 426.35M | 298.90M | 200.16M | 87.80M | 40.26M | 15.16M | 46.84M |
| ROC Equity | -0.36 | -0.26 | 0.25 | -0.85 | -0.44 | -0.59 | N/A | -0.09 | -3.76 | -1.05 | -0.33 |